To further elucidate the potential of DPP4 enzyme activity as a biomarker for IBD, the aim of this study was to quantify DPP4 specific activity in bio-banked plasma samples from patients with CD and UC. This evidence concerns the gene DPP4 and inflammatory bowel disease.